WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Insulin detemir

Governed registry record

3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial.

    DOI: 10.1016/s2213-8587(22)00307-2

    Source identity and connection checked by Codex (AI).

  2. Insulin detemir in the treatment of type 1 and type 2 diabetes.

    DOI: 10.2147/vhrm.2006.2.3.277

    Source identity and connection checked by Codex (AI).

  3. Pharmacology of insulin detemir.

    DOI: 10.1016/s0889-8529(07)80004-1

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Mathiesen ER
  • Alibegovic AC
  • Corcoy R
  • Dunne F
  • Feig DS
  • Hod M
  • Jia T
  • Kalyanam B
  • Kar S
  • Kautzky-Willer A
  • Marchesini C
  • Rea RD
  • Damm P
  • EXPECT study group
  • Kurtzhals P
  • Scheen AJ
  • Radermecker RP
  • Philips JC
  • Paquot N
  • Scheen A